Oxaliplatin/CPT-11 for Extensive Stage Small Cell Lung Cancer
The purpose of this study is to determine the safety and effectiveness of the combination of oxaliplatin and irinotecan (CPT-11) in patients with previously untreated, advanced small cell lung cancer.
Small Cell Lung Cancer
DRUG: Irinotecan (CPT-11)|DRUG: Oxaliplatin (Eloxatin)
The purpose of this study is to determine the safety and effectiveness of the combination of oxaliplatin and irinotecan (CPT-11) in patients with previously untreated, advanced small cell lung cancer.